Obsessive-compulsive disorder (OCD) is a common, often misunderstood mental health condition. While it can be highly disruptive to daily life, OCD is also one of the most treatable psychiatric disorders when evidence-based care is used. Still, many people delay treatment because they are unsure what actually works or how to access care efficiently – especially busy parents and professionals in California who may need flexible options like telepsychiatry.

Understanding Obsessive-Compulsive Disorder

OCD is defined by the presence of obsessions, compulsions, or both. Obsessions are unwanted, intrusive thoughts, urges, or mental images that cause distress. Compulsions are repetitive behaviors or mental acts performed in an attempt to reduce that distress or prevent a feared outcome. Common examples include contamination fears with excessive washing, intrusive harm thoughts followed by checking, or intense discomfort with asymmetry leading to arranging or counting rituals. These symptoms are not simply habits or preferences; they are driven by changes in brain circuitry involved in threat detection and habit formation [1,2].

Of note, many patients often feel a ‘need’ to complete a compulsion (like checking something), even though they don’t ‘want’ to do it. Some compulsions can even include self-harm.

OCD can affect people of all ages and often interferes with work, school, relationships, and overall quality of life. Without treatment, symptoms tend to persist, though severity may fluctuate over time.

How OCD Is Diagnosed and Monitored

Diagnosis of OCD is made through a clinical evaluation conducted by a qualified psychiatric provider. This assessment includes a detailed discussion of symptoms, their impact on daily functioning, and the presence of other mental health conditions such as depression, anxiety disorders, or tic disorders, which commonly co-occur with OCD [2].

To better understand symptom severity and track treatment response, standardized assessment tools are often used. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) is considered the gold standard for measuring OCD severity and monitoring improvement over time [3]. Shorter screening tools, such as the Obsessive-Compulsive Inventory-Short Version (OCI-SV) and the Florida Obsessive Compulsive Inventory, are also commonly used and have demonstrated strong reliability and sensitivity to change with treatment [3].

These tools help psychiatric providers make informed decisions about treatment adjustments and long-term management.

Evidence-Based First-Line Treatment Options

Clinical guidelines consistently identify two first-line treatments for OCD: cognitive behavioral therapy with exposure and response prevention (ERP) and selective serotonin reuptake inhibitors (SSRIs). Both approaches are supported by decades of research, and neither is considered universally superior for all patients. Instead, treatment selection depends on symptom severity, patient preference, prior treatment response, and comorbid conditions [2].

While psychotherapy plays an essential role in OCD treatment, psychiatric providers are specifically responsible for diagnosis, medication management, and monitoring the safety and effectiveness of pharmacologic treatment. Many patients receive medication while working with an external therapist for ERP, especially when symptoms are moderate to severe or when therapy access is limited.

Medication Treatment for OCD

SSRIs are the cornerstone of pharmacologic treatment for OCD. Medications such as fluoxetine, sertraline, fluvoxamine, paroxetine, and escitalopram have all demonstrated efficacy. Large reviews show no meaningful difference in effectiveness between individual SSRIs [3].

Unlike depression, OCD often requires higher SSRI doses within FDA-approved limits to achieve optimal symptom reduction. Research shows that these higher doses are modestly but significantly more effective, though they may also increase the risk of side effects, making careful monitoring essential [3]. Improvement often begins after four to six weeks, but a full trial typically requires eight to twelve weeks before determining whether the medication is effective [3].

Medication management involves ongoing follow-up with a psychiatric provider to assess response, manage side effects, and make dose adjustments as needed. For many patients, medication significantly reduces symptom intensity, making daily life more manageable and, in some cases, allowing greater engagement in therapy.

Practices such as Remedy Psychiatry provide medication management through telepsychiatry services, allowing patients across California to access consistent care without the need for in-person visits.

When Combination Treatment Is Helpful

For many individuals, combining medication with ERP leads to better outcomes than either approach alone. Combination treatment is often recommended for patients with more severe symptoms, those who do not respond adequately to one treatment modality, or those with co-occurring conditions such as major depressive disorder [2].

Research also suggests that ERP remains effective even in patients whose symptoms have not fully responded to medication. In addition, ERP may help reduce relapse risk if medication is later tapered or discontinued under medical supervision [2,5]. Psychiatric providers play a central role in coordinating medication treatment while patients pursue therapy elsewhere.

 

Managing Treatment-Resistant OCD

Despite appropriate first-line treatment, approximately 40-60% of patients experience persistent symptoms [3]. When this occurs, psychiatric providers may consider several evidence-based strategies, including switching to a different SSRI, prescribing clomipramine, or short-term augmentation of an SSRI with an antipsychotic medication [3].

Antipsychotic augmentation has shown particular benefit in patients with co-occurring tic disorders, but it also carries risks such as weight gain and metabolic changes. For this reason, guidelines recommend discontinuing augmentation if no clear improvement is seen within six to ten weeks [3].

Importantly, ERP continues to demonstrate strong efficacy even in individuals who have not responded well to medication alone, often outperforming medication augmentation strategies in clinical trials [3]. 

For the most severe and refractory cases, specialized interventions such as neuromodulation approaches, including repetitive transcranial magnetic stimulation, may be considered [1,3].

Accessing OCD Medication Management via Telepsychiatry in California

Telepsychiatry has expanded access to OCD treatment across California, particularly for individuals who face long wait times, geographic barriers, or scheduling challenges. Through telepsychiatry services, psychiatric providers can conduct evaluations, prescribe and adjust medication, and monitor symptoms using validated assessment tools.

For Californians seeking evidence-based medication management for OCD, telepsychiatry services through Remedy Psychiatry offer a practical and accessible option that supports continuity of care without requiring frequent in-person visits.

When to Seek Professional Care

It may be time to consult a psychiatric provider if OCD symptoms interfere with daily functioning, take up more than an hour per day, worsen over time, or are accompanied by significant anxiety or depression. Early and appropriate treatment is associated with better long-term outcomes and reduced disruption to work, school, and family life.

OCD is a chronic condition, but effective treatment can significantly reduce symptoms and improve quality of life. Medication management provided by a psychiatric provider is a key component of care and can be delivered safely and effectively through telepsychiatry. 

Disclaimer:
This content is for educational purposes only and does not constitute medical advice. Treatment decisions should be made in consultation with a qualified psychiatric provider.

Book an Appointment
References:
  1. Goodman WK, Storch EA, Sheth SA. Harmonizing the neurobiology and treatment of obsessive-compulsive disorder. Am J Psychiatry. 2021;178(1):17–29.
  2. Grant JE. Obsessive-compulsive disorder. N Engl J Med. 2014;371(7):646–653.
  3. Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA. 2017;317(13):1358–1367.
  4. Pediatric Acute-Onset Neuropsychiatric Syndrome Clinical Report. Pediatrics. 2025;155(3):e2024070334.
  5. Foa EB, Simpson HB, Gallagher T, et al. Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation. JAMA Psychiatry. 2022;79(3):193–200.

Leave a Reply

Consent Preferences